The data from the trial showed that XV Technology® confirmed the diagnosis of CB with
<0.001% uncertainty, setting it apart from conventional diagnostic methods such as lung imaging
and PFTs, and as a dramatically safer and less expensive alternative to surgical biopsy.
Ann: Vanderblit 'burn pit' trial hits primary endpoint, page-7
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.005(0.95%) |
Mkt cap ! $213.4M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 53.5¢ | 51.0¢ | $175.2K | 337.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 173020 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 162258 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |